7. Technological Developments for New Applications
7.1 Therapeutic proteins and antibodies
The annual market for therapeutic biomolecules is worth more than $300 billion. Recombinant monoclonal antibodies are by far the most prevalent class in this market. In the vast majority of cases, they are produced in CHO cells. Despite their ability to produce fully assembled and functional monoclonal antibodies
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Technological Developments for New Applications
Conclusion
Article included in this offer
"Healthcare technologies"
(
125 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
Bibliography
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
